EA
Ershad Ahamed
About Ershad Ahamed
Data last updated:
Ershad Ahamed is a Director at C-Ihub Accelerator India Private Limited (since 2024) and Director at Bdk Pharma Private Limited (since 2023). The companies operate in Travel and Hospitality and Healthcare. The largest current company by reported revenue is C-Ihub Accelerator India Private Limited at ₹5.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 C-Ihub Accelerator India Private Limited U74999TN2020PTC137135 | Director | 18 Mar 2024 | 2020 | ₹5.91 Cr (FY 2024) | Active |
| Bdk Pharma Private Limited U47721TN2023PTC163430 | Director | 05 Sep 2023 | 2023 | Active |
Board colleagues of Ershad Ahamed
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shahul Hameed Paul Mohamed Thatha | 07002889 | C-Ihub Accelerator India Private Limited | Director |
| Ahamed Faris Noohumohamedameerfizel | 07051350 | Bdk Pharma Private Limited | Director |
| Ahmed Lafir Habib | 10725572 | Bdk Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ershad Ahamed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ershad Ahamed
Ershad Ahamed currently holds 2 directorships: C-Ihub Accelerator India Private Limited (Director, since 18 Mar 2024, revenue ₹5.91 Cr (FY 2024)); Bdk Pharma Private Limited (Director, since 05 Sep 2023).
Ershad Ahamed was first appointed on 05 Sep 2023 as Director at Bdk Pharma Private Limited. The most recent appointment on record is 18 Mar 2024 at C-Ihub Accelerator India Private Limited.
The current boards of Ershad Ahamed's companies include Shahul Hameed Paul Mohamed Thatha (C-Ihub Accelerator India Private Limited), Ahamed Faris Noohumohamedameerfizel (Bdk Pharma Private Limited), Ahmed Lafir Habib (Bdk Pharma Private Limited).